U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 1671 - 1680 of 141793 results

Status:
Investigational
Source:
INN:flizasertib [INN]
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Status:
Investigational
Source:
INN:docirbrutinib [INN]
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Status:
Investigational
Source:
INN:obeldesivir [INN]
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Status:
Investigational
Source:
INN:bocidelpar [INN]
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Status:
Investigational
Source:
INN:muvalaplin [INN]
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Status:
Investigational
Source:
NCT02284919: Phase 1 Interventional Active, not recruiting Breast Cancer
(2014)
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

ISO-1 F-18 is a benzamide analog radiolabeled with 18F. It is a sigma-2 receptor ligand. Since sigma-2 receptor is expressed in higher density in proliferating tumor cells versus quiescent tumor cells, ISO-1 F-18 can be used as a positron emission tomography (PET) tracer to evaluate tumor proliferation by PET in patients with malignant neoplasms. Currently, ISO-1 F-18 in Phase I clinical trial as an investigational radiotracer in primary breast cancer.
Status:
Investigational
Source:
NCT02675660: Phase 1 Interventional Completed Healthy
(2014)
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Status:
Investigational
Source:
NCT04440007: Phase 2 Interventional Completed Covid-19
(2020)
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)


Status:
Investigational
Source:
INN:icotrokinra [INN]
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Status:
Investigational
Source:
INN:actinium (<sup>225</sup>Ac) zadavotide guraxetan [INN]
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Showing 1671 - 1680 of 141793 results